Home   l   Log in   l     
Lilly Asia Ventures, founded in 2008, is dedicated to venture capital investments in the life sciences and healthcare sectors in Asia, particularly in China. Its investors include
Eli Lilly & Co., a Fortune 500 company and one of the most globalized and innovative pharmaceutical companies in the world. As a leading biomedical venture fund in China, Lilly Asia Ventures provides wise capital, industry expertise, and global resources to its portfolio companies to accelerate their growth.
 Room 2909, 3 Corporate Avenue, No.168 Hubin Road  
 +86 21 2316 9588  
copyright © 2012-2015 Lilly Asia Ventures all rights reserved.